A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin.

Witkowski, Michal; Wilkinson, Lars; Webb, Neil; Weids, Alan; Glah, Divina; Vrazic, Hrvoje

Witkowski, Michal; Wilkinson, Lars; Webb, Neil; Weids, Alan; Glah, Divina; Vrazic, Hrvoje.

Affiliation

Witkowski M; DRG Abacus, Bicester, Oxfordshire, UK.
Wilkinson L; Novo Nordisk A/S, Søborg, Denmark.
Webb N; DRG Abacus, Bicester, Oxfordshire, UK. nwebb@teamdrg.com.
Weids A; DRG Abacus, Bicester, Oxfordshire, UK.
Glah D; Novo Nordisk Ltd., Gatwick, UK.
Vrazic H; Novo Nordisk A/S, Søborg, Denmark.

Diabetes Ther ; 9(3): 1233-1251, 2018 Jun.

Article in En | MEDLINE | ID: mdl-29713961

Key words

Basal insulin; GLP-1 receptor agonist; Glycemic control; HbA1c; Network meta-analysis; Semaglutide; Systematic review; Systolic blood pressure; Type 2 diabetes; Weight

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Diabetes Ther Year: 2018 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google